Navigation Links
Corkscrew™ II Suture Anchor

ProductsCorkscrew™ II Suture Anchor
Company Arthrex
Item Corkscrew™ II Suture Anchor
Features 
  • Two individual suture eyelets
  • Rotator cuff repair
  • Soft tissue anchoring
  • Two sutures
  • Cancellous threads
  • Maximum pull-out strength in soft bone
  • Optional attachable handle
  • FiberWire option
  • Description The Corkscrew II is a 5 mm suture anchor that incorporates a small minor diameter and a cancellous screw thread design for maximum pull-out strength in soft bone. The anchor has two individual eyelets to minimize the possibility of locking the second suture after the first suture is tied. The vertical laser mark on the distal part of the insertion shaft indicates the orientation of the suture eyelets. When the anchor is inserted, the vertical laser mark should point toward the cuff tendon to ensure the suture slides smoothly through the tissue and eyelet minimizing suture abrasion and sliding resistance. The sharp, conical tip ensures that positioning on bone and ease of starting will be accomplished with little effort. The Corkscrew II is supplied sterile and preloaded on a disposable handled inserter with two strands of #2 FiberWire suture or Tevdek suture. A Corkscrew Starter Awl is available should the surgeon encounter very hard bone and subsequent difficulties starting the anchor in indications other than the humeral head. This Awl requires a handle such as the Tear Drop Handle or the Ratcheting Screwdriver Handle. A Reusable Corkscrew Handle is available for surgeons who prefer a larger handle.
    Info Arthrex
    Customer Service: (800) 933-7001
    Web site: http://www.arthrex.com

    Related medicine products :

    1. Bio-Corkscrew™ Suture Anchor w/Needles
    2. Bio-Corkscrew™ Suture Anchor w/NeedlePunch Needles
    3. Bio-Corkscrew™ FT Suture Anchor
    4. Corkscrew™ Parachute Tissue Anchor
    5. Bio-Corkscrew™ Suture Anchor
    6. Corkscrew™ FT II Suture Anchor
    7. Corkscrew™ Suture Anchor
    8. Serdarevic Suture Hook
    9. Castroviejo Suture Forceps
    10. OGawa Straight Suture-Fixation Forceps - 0.12 mm
    11. Colibri Suture Removal Forceps
    The Acceava Mononucleosis test provides superior performance for the diagnosis of Mononucleosis with a simple procedure that provides an answer in 6 minutes. Side-by-side evaluations with competitive
    ... first available point-of-care diagnostic test tha... influenza A and B. The test uses a unique substra...ists viral replication by promoting the release of...rate is labeled with a chromagen. When influenza v...
    ...fluenza Test detects Influenza type A and B viral ...nasal aspirate/nasal wash specimen. Test results a...e, easy-to-read kit can be stored at room temperat...it is conveniently packaged for single-use testing...
    Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets.
    Medicine Products:
    (Date:7/25/2008)...es lung function, increases asthma risk, studies f...ews) -- A clean, fresh-smelling home may actually ...cleaning and air freshening products you use. ,...g products or air fresheners that contain a certai...lorobenzene (1,4 DCB), can reduce lung function by...
    (Date:7/25/2008)...umers tips and encourages them to, ,Speak Up,(TM)...ly 25 /PRNewswire-USNewswire/ -- The Pennsylvania,...Patient Safety Day" which,is a national effort to ...te fully in their healthcare by asking questions a...y or illness., "We understand the important role ...
    (Date:7/25/2008)...Fourth Annual Physician On-Call Pay ...swire/ -- Sullivan, Cotter and Associates, Inc.,ha...on-call pay rates and,practices, the 2008 Physicia...th data from 132 healthcare organizations nationwi...ates paid for 33 physician specialty areas along,w...
    (Date:7/25/2008)...icant Improvements in Members, Health, ATLANTA, J...n health,care quality management solutions for hea...tered into a long-term agreement with Wellmark, In... on Quality(SM) Incent and,Reward Best Practices i...imary care clinicians to promote improved quality ...
    Breaking Medicine News(10 mins):Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3
    ...tool to treat drug-resistant HIV thanks to a new m...// "There are many treatments for AIDS on the mark...said Arun Ghosh (pronounced A-rune GO-sh), a profe...partments of chemistry and medicinal chemistry and...
    ...ffer from stress urinary incontinence (SUI), a con...an lead to urine leakage.// “We try to treat pati... better bladder habits, doing Kegel exercises, and...coughing, infections and hormone deficiencies—all ...
    ...ndometrial cancer should be screened for inherited...al other cancers.// The study showed that 1.8 per...etrial cancer patients have mutations for Lynch sy...wn as hereditary nonpolyposis colon cancer, or HNP...
    ...-borne viruses is well known; a bite on the body t...od stream. But what happens next that causes the v...searchers led by a Howard Hughes Medical Institute...been able to point at a genetic element which help...
    Other Medicine News:Health News:Research Leads to First Treatment for Drug-Resistant HIV 2Health News:Research Leads to First Treatment for Drug-Resistant HIV 3Health News:Research Leads to First Treatment for Drug-Resistant HIV 4Health News:Uterine Cancer May be Clue to Inherited Syndrome 2Health News:Uterine Cancer May be Clue to Inherited Syndrome 3Health News:The Dengue Virus Unplugged 2Health News:The Dengue Virus Unplugged 3
    (Date:7/22/2008)...wo Regimens Including Lantus(R) and Apidra(R) Resu... with Type 2 Diabetes, Whatever the Algorithm ....J., July 22 /- Results from the "Adj...Simple Algorithm to Carbohydrate,Counting for Adju...published in the American Diabetes Association,s (...
    (Date:7/22/2008)...SOUTH SAN FRANCISCO, Calif., July 22 /PRNewswire/ ...t it has completed patient enrollment,in its Phase...bility and,ammonia scavenging effects of HPN-100 (...henylbutyrate) in patients with urea cycle disorde...esults in the fourth quarter,of this year., (Logo...
    (Date:7/22/2008)... Developed and Validated by Columbia University Me...Proprietary MicroRNA Technology, The Test Differ... Lung Cancer (NSCLC), Classifying Squamous-Cell C... Percent and Specificity of 90 Percent,This is the...s, Sensitivity as Biomarkers for Accurate...
    (Date:7/22/2008)...SOPHIA ANTIPOLIS, France, July 22 /PRNewswire-Firs...nnounced it has successfully completed the,enrollm...olled hypertension,in two clinical pharmacology st...y announced timelines. These trials are designed t..., in comparison to ibuprofen and,naproxen, using t...
    Breaking Medicine Technology:Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Alexzas AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2a Trial Meets Primary Endpoint of 2 Hour Pain Relief in Patients with Migraine Headache 1451 1Alexzas AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2a Trial Meets Primary Endpoint of 2 Hour Pain Relief in Patients with Migraine Headache 1451 2Alexzas AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2a Trial Meets Primary Endpoint of 2 Hour Pain Relief in Patients with Migraine Headache 1451 3Alexzas AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2a Trial Meets Primary Endpoint of 2 Hour Pain Relief in Patients with Migraine Headache 1451 4Alexzas AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2a Trial Meets Primary Endpoint of 2 Hour Pain Relief in Patients with Migraine Headache 1451 5Alexzas AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2a Trial Meets Primary Endpoint of 2 Hour Pain Relief in Patients with Migraine Headache 1451 6Alexzas AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2a Trial Meets Primary Endpoint of 2 Hour Pain Relief in Patients with Migraine Headache 1451 7Alexzas AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2a Trial Meets Primary Endpoint of 2 Hour Pain Relief in Patients with Migraine Headache 1451 8The Quigley Corporation Announces Sale of Its Health and Wellness Segment 13232 1The Quigley Corporation Announces Sale of Its Health and Wellness Segment 13232 2The Quigley Corporation Announces Sale of Its Health and Wellness Segment 13232 3Up for Debate This Week 3A National Service Mental Health Coverage and Consumer Product Safety 13227 1Up for Debate This Week 3A National Service Mental Health Coverage and Consumer Product Safety 13227 2Up for Debate This Week 3A National Service Mental Health Coverage and Consumer Product Safety 13227 3NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis 3644 1NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis 3644 2NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis 3644 3NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis 3644 4NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis 3644 5